SGAM
CRTX

Smith Group Asset Management’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Smith Group Asset Management’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,786
Closed -$14K – 469
2013
Q2 		$14K Buy
+1,786
New +$15.1K ﹤0.01% 312

Other funds holding CRTX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOM
Loeb Offshore Management New York $547M AUM 50.11% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Smith Group Asset Management's CRTX Position: Q3 2013 in Review

Smith Group Asset Management sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q3 2013, closing a stake of 1,786 shares — an estimated $14K sold.

Smith Group Asset Management first reported a position in CRTX in Q2 2013 and held it in 1 quarter. The position peaked at $14K in Q2 2013. 64 funds tracked by Wall St. Rank hold CRTX as of Q3 2013.

  • Smith Group Asset Management reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q3 2013 after selling out during the quarter.
  • Smith Group Asset Management sold 1,786 CORNERSTONE THERAPEUTICS INC shares in Q3 2013, an estimated $14K.
  • Smith Group Asset Management first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 1 quarter.
  • Smith Group Asset Management's CORNERSTONE THERAPEUTICS INC position peaked at $14K in Q2 2013.
  • 64 funds tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q3 2013.

Based on Smith Group Asset Management's 13F filing for Q3 2013, filed 29 Oct 2013.